Official Title
Lung Structure-Function In SurVivors of Mild and SEvere COVID-19 Infection: 129Xe MRI For Rapid Evaluation and NExt-wave Healthcare Planning
Brief Summary

In this study the Investigators aim to deploy UTE and HP 129Xe MRI for structural and functional evaluation of persistent lung abnormalities in COVID-19 survivors.

Detailed Description

What is COVID-19? The ongoing Coronavirus Disease 2019 (COVID-19) pandemic is caused when an
individual is infected with the SARS-CoV-2 virus. This infection can result in pneumonia
involving the small airways and alveoli (the tiny air sacs at the end of the airways that
help oxygen get into the blood). COVID-19 can cause damage to the lungs, making it hard to
breathe without medical help. To understand what is happening to a patient's lungs, doctors
may use imaging tests such as chest x-rays or CT Scans (computed tomography). However, these
types of tests may not tell the Investigators the whole story.

What is the purpose of the study? Led by The Hospital for Sick Children (SickKids), this
study is being done to determine if MRI (magnetic resonance imaging) scans can tell the
Investigators more about the lungs of people who had COVID-19. The Investigators will use a
special type of MRI where participants breathe in a special gas (hyperpolarized xenon-129)
before they have the MRI. This gas will help the Investigators to see' the lungs. The
advantage of MRI scans is that there is no radiation involved in these types of images.

What is involved? In this study, participants will have an MRI of their lungs. The
Investigators will examine these MRI scans to see if the Investigators can identify any
changes in the structure or the function of the lung. If the Investigators do find any
changes, they will see how these changes relate to other tests that have been conducted or
other parts of the clinical story.

The participants will be asked to come to SickKids for 3 study visits. A fourth visit will be
conducted via telephone. These visits will span over 3 years. Each study visit will take
about 4 hours. If the participant is unable to attend one of the in-person visits, they will
be given the option for a phone/virtual visit instead.

Recruiting
COVID-19 Respiratory Infection

Drug: 129Xenon gas

Observational
Other Name: Hyperpolarized tracer gas

Eligibility Criteria

Inclusion Criteria:

- Consent provided

- Aged 12-70 years old

- Meets MRI screening criteria

- Diagnosed with COVID19, documented by positive COVID19 test (Nasopharyngeal swab or
saliva swab) and are within 3 months post recovery*.

- Recovery from COVID19 is defined as asymptomatic for at least 2 weeks prior to
study visit 1 and screen negative based on SickKids guidelines.

Exclusion Criteria:

- Pregnant or lactating*

- A cold or flu within the last 2 weeks

Eligibility Gender
All
Eligibility Age
Minimum: 12 Years ~ Maximum: 70 Years
Countries
Canada
Locations

The Hospital for Sick Children
Toronto, Ontario, Canada

Investigator: Giles Santyr, PhD FCCPM
giles.santyr@sickkids.ca

Investigator: Giles Santyr, PhD FCCPM

Contacts

giles Santyr, PhD
416-813-7654 - 301394
giles.santyr@sickkids.ca

Sharon Braganza, MSc
4168137654 - 307937
sharon.braganza@sickkids.ca

Western University
NCT Number
Keywords
Lung MRI
129Xenon
MeSH Terms
Infections
Communicable Diseases
COVID-19
Respiratory Tract Infections
Xenon